Characterization of tissue tropism determinants of adeno-associated virus type 1.
about
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia BEfficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectorsCross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroupsSelf-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genomeRecombination in eukaryotic single stranded DNA virusesAdeno-associated virus-mediated cancer gene therapy: current statusStructural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal TraffickingStructure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene TransferComparative analysis of adeno-associated virus capsid stability and dynamicsIn vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.Molecular engineering of viral gene delivery vehiclesDNA shuffling of adeno-associated virus yields functionally diverse viral progenyDirected evolution of adeno-associated virus for glioma cell transductionStructure of adeno-associated virus type 4.Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuriaTransient demyelination increases the efficiency of retrograde AAV transductionPreclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production methodAAV ancestral reconstruction library enables selection of broadly infectious viral variants.Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).Adeno-associated virus vectors: potential applications for cancer gene therapy.Surface loop dynamics in adeno-associated virus capsid assembly.A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotypeBioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals.Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of Hemophilia.Microvesicle-associated AAV vector as a novel gene delivery system.C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice.Mapping the structural determinants responsible for enhanced T cell activation to the immunogenic adeno-associated virus capsid from isolate rhesus 32.33.Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors.Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
P2860
Q21245486-D757AB5E-3D85-42AF-8534-8B6FF2761A02Q24538483-753081A3-46C2-4428-A306-9D2E3D5B23BCQ24623923-02936CB9-4CE6-42DC-B038-647695563400Q24625426-47F7EF8D-FCAE-4D00-BE65-45A704F66F7DQ27008438-8FC55693-CCD3-41A5-AB7B-0F23057D0FE5Q27026177-1779413E-441F-44E5-A795-0CA4460728C0Q27664641-4604F96A-873D-418A-BBFA-DB60306209C8Q27673394-57EC8AA4-6BBF-4118-8A57-8EE794231E49Q27681034-FC9C67F0-A9F5-49FA-8A44-42BC48504431Q30152887-AAA15B84-77B9-441B-B875-FA04C1BDEACEQ30557598-80E85CEE-294D-4C32-879B-A21F1AB58204Q33327474-C105050C-6196-4ECE-B817-A74C7D54B0A8Q33353795-3E6B2A19-4161-4B7B-B95F-7E97DAC4D6B4Q33363531-1E0C7168-BE8F-4E77-901C-B92752828146Q33484220-D57DC6C7-3BF3-46B4-B636-B490FD5F2F94Q33724158-921972CC-9CF1-4359-9137-3E108C898C31Q33832790-65B08FE9-C356-45EE-90CE-DA8A9B5BB6C6Q34080900-A67D90CF-0FE4-484F-998C-DC4ED601A84AQ34589262-DB67CA5C-E398-4472-8229-580297F9A1DCQ35695082-7EAC7D39-B34C-464E-A4F8-943A56E9FFE8Q35904461-CDD0DACD-ECC3-401F-91FC-9A7DD15DE31FQ36165834-D51B488E-9BCB-40A3-9992-A3DAD0B1D62DQ36673382-470E9EBC-9741-46CC-8840-CDDD95D1A8F4Q36715338-B677F7C0-16D5-43F9-B452-AA289086CE45Q37198468-DE0D6B17-1A1B-4A2C-8D76-8E89FFE6543BQ37205966-E476B087-76A9-4D68-B6A2-E50383DB1DDAQ38069585-52F11FC6-C068-416B-9BCA-A86DEF4F680AQ39400043-64648AEE-2F20-446C-B42B-4AB3802D0B18Q42030992-9B57C4D9-256A-4664-82CE-F2445A9BA782Q42054746-49E57510-418F-4D2F-A19E-75DDF3870C2CQ42203239-375086C9-FD74-4DA4-BE30-41C700A8F1D5Q42252699-76E53B47-8902-4D95-B232-D6398D4FE02AQ45457856-63CF6D5F-6BE3-4C99-B813-3A1F553E3EB4Q45858191-325A88E5-7516-4A9C-9344-E2A0FE27383CQ45859037-2DA21481-F828-40D4-9C35-9658248841E6Q45886068-7770B09D-437F-497B-8F20-6F03B3CE3557Q58795206-148B1520-B119-4C45-982F-96FEE4A004D9
P2860
Characterization of tissue tropism determinants of adeno-associated virus type 1.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Characterization of tissue tropism determinants of adeno-associated virus type 1.
@en
Characterization of tissue tropism determinants of adeno-associated virus type 1.
@nl
type
label
Characterization of tissue tropism determinants of adeno-associated virus type 1.
@en
Characterization of tissue tropism determinants of adeno-associated virus type 1.
@nl
prefLabel
Characterization of tissue tropism determinants of adeno-associated virus type 1.
@en
Characterization of tissue tropism determinants of adeno-associated virus type 1.
@nl
P2860
P1433
P1476
Characterization of tissue tropism determinants of adeno-associated virus type 1.
@en
P2093
Bernd Hauck
Weidong Xiao
P2860
P304
P356
10.1128/JVI.77.4.2768-2774.2003
P407
P577
2003-02-01T00:00:00Z